Since colonic CHI3L1 is known to be inducibly expressed in IECs during the course of IBD which is further overexpressed when CAC develops, quantifying CHI3L1 levels using easily accessible sample collection and methods may help to develop a new diagnostic strategy for predicting the neoplastic changes of IECs in IBD patients. Here, CHI3L1 is linked to inflammatory bowel disease.